ECSP14024263A - USO DE 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS EN EL TRATAMIENTO DE MENORRAGIA, Y SISTEMAS INTRAUTERINOS QUE COMPRENDEN 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS PARA EL TRATAMIENTO DE TRASTORNOS CON SANGRADO UTERINO - Google Patents

USO DE 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS EN EL TRATAMIENTO DE MENORRAGIA, Y SISTEMAS INTRAUTERINOS QUE COMPRENDEN 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS PARA EL TRATAMIENTO DE TRASTORNOS CON SANGRADO UTERINO

Info

Publication number
ECSP14024263A
ECSP14024263A ECIEPI201424263A ECPI201424263A ECSP14024263A EC SP14024263 A ECSP14024263 A EC SP14024263A EC IEPI201424263 A ECIEPI201424263 A EC IEPI201424263A EC PI201424263 A ECPI201424263 A EC PI201424263A EC SP14024263 A ECSP14024263 A EC SP14024263A
Authority
EC
Ecuador
Prior art keywords
methyl
treatment
espirox
onas
methylen
Prior art date
Application number
ECIEPI201424263A
Other languages
English (en)
Inventor
Norbert Schmees
Henriikka Korolainen
Tuula Valo
Katja Prelle
Reinhard Nubbemeyer
Harri Jukarainen
Lars Röse
Original Assignee
Poli Nutri Alimentos S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48141995&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP14024263(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Poli Nutri Alimentos S A filed Critical Poli Nutri Alimentos S A
Publication of ECSP14024263A publication Critical patent/ECSP14024263A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Uso intrauterino de 18-metil-15ß;,16ß;-metilen-19-nor-20-espirox-4-en-3-onas de fórmula general (1), en donde R6 y R7 son hidrógeno o un grupo metileno, para el tratamiento de la menorragia, de hemorragias intrauterinas en general, y un sistema intrauterino para dicho uso, que comprende un compuesto de fórmula 1.
ECIEPI201424263A 2012-04-23 2014-10-24 USO DE 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS EN EL TRATAMIENTO DE MENORRAGIA, Y SISTEMAS INTRAUTERINOS QUE COMPRENDEN 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS PARA EL TRATAMIENTO DE TRASTORNOS CON SANGRADO UTERINO ECSP14024263A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102012206653 2012-04-23

Publications (1)

Publication Number Publication Date
ECSP14024263A true ECSP14024263A (es) 2015-12-31

Family

ID=48141995

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI201424263A ECSP14024263A (es) 2012-04-23 2014-10-24 USO DE 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS EN EL TRATAMIENTO DE MENORRAGIA, Y SISTEMAS INTRAUTERINOS QUE COMPRENDEN 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS PARA EL TRATAMIENTO DE TRASTORNOS CON SANGRADO UTERINO

Country Status (28)

Country Link
US (1) US20150119372A1 (es)
EP (1) EP2841073A1 (es)
JP (1) JP2015514789A (es)
KR (1) KR20150005548A (es)
CN (1) CN104379149A (es)
AR (1) AR090800A1 (es)
AU (1) AU2013251842A1 (es)
BR (1) BR112014026086A2 (es)
CA (1) CA2871001A1 (es)
CL (1) CL2014002857A1 (es)
CO (1) CO7111253A2 (es)
CR (1) CR20140489A (es)
CU (1) CU20140120A7 (es)
DO (1) DOP2014000240A (es)
EA (1) EA201491917A1 (es)
EC (1) ECSP14024263A (es)
GT (1) GT201400225A (es)
HK (1) HK1206271A1 (es)
IL (1) IL235096A0 (es)
MA (1) MA37443A1 (es)
MX (1) MX2014012848A (es)
PE (1) PE20142437A1 (es)
PH (1) PH12014502371A1 (es)
SG (1) SG11201406583QA (es)
TN (1) TN2014000445A1 (es)
TW (1) TW201345530A (es)
UY (1) UY34759A (es)
WO (1) WO2013160200A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30867A (en) 1992-07-31 1997-12-09 Leiras Oy Method and equipment for installing a medicine capsule on a support.
FI90627C (fi) 1992-07-31 1994-03-10 Leiras Oy Laitteisto lääkeainesauvan varustamiseksi vaipalla
FI107339B (fi) 1998-06-30 2001-07-13 Leiras Oy Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi
US6056976A (en) 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
DE102006030416A1 (de) 2006-06-29 2008-01-03 Bayer Schering Pharma Ag 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
JP2015514789A (ja) 2015-05-21
MA37443A1 (fr) 2016-05-31
IL235096A0 (en) 2014-12-31
PE20142437A1 (es) 2015-01-31
MX2014012848A (es) 2015-02-05
BR112014026086A2 (pt) 2017-07-18
CU20140120A7 (es) 2015-02-26
CO7111253A2 (es) 2014-11-10
PH12014502371A1 (en) 2015-01-12
EP2841073A1 (de) 2015-03-04
UY34759A (es) 2013-11-29
CA2871001A1 (en) 2013-10-31
US20150119372A1 (en) 2015-04-30
AU2013251842A1 (en) 2014-11-06
AR090800A1 (es) 2014-12-10
CL2014002857A1 (es) 2015-02-06
CN104379149A (zh) 2015-02-25
TN2014000445A1 (en) 2016-03-30
TW201345530A (zh) 2013-11-16
EA201491917A1 (ru) 2015-04-30
DOP2014000240A (es) 2015-02-15
KR20150005548A (ko) 2015-01-14
SG11201406583QA (en) 2014-11-27
HK1206271A1 (en) 2016-01-08
WO2013160200A1 (de) 2013-10-31
CR20140489A (es) 2014-12-24
GT201400225A (es) 2016-01-22

Similar Documents

Publication Publication Date Title
CL2016001082A1 (es) Proceso para la síntesis de un inhibidor de indolamina 2,3-dioxigenasa
UY35500A (es) Indazoles sustituidos con heteroarilo
CL2017002604A1 (es) Sondas duales silenciadoras
UY34617A (es) Composiciones veterinarias orales parasiticidas que comprenden agentes activos de acción sistémica, métodos y usos de las mismas
CL2012002189A1 (es) Compuestos derivados de pirrolidina-2-carboxamidas sustituidas; inhibidores de la interaccion mdm2-p53; composicion farmaceutica; y su uso para el tratamiento del cancer, en particular de tumores solidos.
MX386055B (es) Uso de medicamentos para disminuir la evolución de la enfermedad de parkinson.
DOP2016000089A (es) Sistema de administracion intrauterina
MX394430B (es) Proceso para la preparación de 5-fluoro-1h-pirazoles.
CY1123219T1 (el) Βελτιωμενα αντισωματα αλφα v βητα 8
ES2664171T3 (es) Aditivo retardador del fraguado y plastificante para el hormigón
GT201400146A (es) Composiciones farmacéuticas tópicas que comprenden bexaroteno y corticosteroides
BR112015024877A2 (pt) vacinas que compreendem polipeptídeos de leishmania para o tratamento e diagnóstico de leishmaniose
ECSP14024263A (es) USO DE 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS EN EL TRATAMIENTO DE MENORRAGIA, Y SISTEMAS INTRAUTERINOS QUE COMPRENDEN 18-METIL-15ß,16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS PARA EL TRATAMIENTO DE TRASTORNOS CON SANGRADO UTERINO
CU20140121A7 (es) USO INTRAUTERINO DE 18–METIL–15ß,16ß–METILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18–METIL–15ß,16ß–METILEN–19–NOR–20–ESPIROX–4–EN–3–ONAS, ASÍ COMO SU USO EN LA ANTICONCEPCIÓN Y TERAPIA GINECOLÓGICA
CL2016000586A1 (es) Composición que comprende fósforo para uso en prevenir deformidades en peces triploides
AR098060A1 (es) Sistema de administración intrauterina